{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:43:26Z","timestamp":1760244206480,"version":"3.40.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejps.2024.106799","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:23:12Z","timestamp":1715703792000},"page":"106799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A commentary on \u201cAre all measures of liver Kpuu a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?\u201d"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-1786","authenticated-orcid":false,"given":"Kiyohiko","family":"Sugano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106799_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2524-0","article-title":"The extended clearance concept following oral and intravenous dosing: theory and critical analyses","volume":"35","author":"Benet","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106799_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106753","article-title":"Are all measures of liver Kpuua function of FH, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?","volume":"196","author":"Benet","year":"2024","journal-title":"Eur. J. Pharmaceutical Sci."},{"key":"10.1016\/j.ejps.2024.106799_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12248-021-00591-z","article-title":"There is only one valid definition of clearance: critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions","volume":"23","author":"Benet","year":"2021","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2024.106799_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5599\/admet.3.1.144","article-title":"The extended clearance model and its use for the interpretation of hepatobiliary elimination data","volume":"3","author":"Camenisch","year":"2015","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2024.106799_bib0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2024.106799_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.xphs.2023.05.019","article-title":"A complete extension of classical hepatic clearance models using fractional distribution parameter fd in physiologically based pharmacokinetics","volume":"113","author":"Jeong","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106799_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01062937","article-title":"Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method","volume":"15","author":"Miyauchi","year":"1987","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2024.106799_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a well-stirred model and a parallel tube model. Influence of hepatic blood flow, plasma and blood cell","volume":"5","author":"Pang","year":"1977","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2024.106799_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3187","article-title":"Coexistence of passive and carrier-mediated processes in drug transport","volume":"9","author":"Sugano","year":"2010","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2024.106799_bib0010","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/dmd.123.001344","article-title":"A 20-year research overview: quantitative prediction of hepatic clearance using the in vitro-in vivo extrapolation approach based on physiologically based pharmacokinetic modeling and extended clearance concept","volume":"51","author":"Sugiyama","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2024.106799_bib0011","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106799_bib0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"A physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin. Pharma Therapeutics"},{"key":"10.1016\/j.ejps.2024.106799_bib0013","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1016077517241","article-title":"Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics","volume":"13","author":"Yamazaki","year":"1996","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T22:44:56Z","timestamp":1717022696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":13,"alternative-id":["S0928098724001118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106799","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A commentary on \u201cAre all measures of liver Kpuu a function of FH, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?\u201d","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106799"}}